All news

Guggenheim starts Disc Medicine at Buy with

Alpha Vantage · TradingView · · AI-summarised by FinFlash

Guggenheim has initiated coverage of Disc Medicine (IRON) with a Buy rating and a price target of

Read original source

IRON company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.